Metformin: A Diabetes Drug for Cancer, or a Cancer Drug for Diabetics?

被引：41

作者：

Martin, Matthew ^{[1
]}

Marais, Richard ^{[2
]}

机构：

[1] Inst Canc Res, London SW3 6JB, England

[2] Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 21期

关键词：

ACTIVATED PROTEIN-KINASE; CELL-CYCLE ARREST; GROWTH; AMPK; PHOSPHORYLATION; RISK; TSC2; STIMULATION; INHIBITION; SUPPRESSES;

D O I：

10.1200/JCO.2012.42.1677

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2698 / 2700

页数：3

共 29 条

[1] Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro [J].

Alimova, Irina N. ;

Liu, Bolin ;

Fan, Zeying ;

Edgerton, Susan M. ;

Dillon, Thomas ;

Lind, Stuart E. ;

Thor, Ann D. .

CELL CYCLE, 2009, 8 (06) :909-915

[2] Metformin, an Antidiabetic Agent, Suppresses the Production of Tumor Necrosis Factor and Tissue Factor by Inhibiting Early Growth Response Factor-1 Expression in Human Monocytes in Vitro [J].

Arai, Masatoku ;

Uchiba, Mitsuhiro ;

Komura, Hidefumi ;

Mizuochi, Yuichiro ;

Harada, Naoaki ;

Okajima, Kenji .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01) :206-213

[3] Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers [J].

Baumgarten, Sarah C. ;

Frasor, Jonna .

MOLECULAR ENDOCRINOLOGY, 2012, 26 (03) :360-371

[4] Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1 [J].

Ben Sahra, Isaam ;

Regazzetti, Claire ;

Robert, Guillaume ;

Laurent, Kathiane ;

Le Marchand-Brustel, Yannick ;

Auberger, Patrick ;

Tanti, Jean-Francois ;

Giorgetti-Peraldi, Sophie ;

Bost, Frederic .

CANCER RESEARCH, 2011, 71 (13) :4366-4372

[5] Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer [J].

Bodmer, Michael ;

Meier, Christian ;

Krahenbuehl, Stephan ;

Jick, Susan S. ;

Meier, Christoph R. .

DIABETES CARE, 2010, 33 (06) :1304-1308

[6] Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial [J].

Bonanni, Bernardo ;

Puntoni, Matteo ;

Cazzaniga, Massimiliano ;

Pruneri, Giancarlo ;

Serrano, Davide ;

Guerrieri-Gonzaga, Aliana ;

Gennari, Alessandra ;

Trabacca, Maria Stella ;

Galimberti, Viviana ;

Veronesi, Paolo ;

Johansson, Harriet ;

Aristarco, Valentina ;

Bassi, Fabio ;

Luini, Alberto ;

Lazzeroni, Matteo ;

Varricchio, Clara ;

Viale, Giuseppe ;

Bruzzi, Paolo ;

DeCensi, Andrea .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2593-2600

[7] Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women [J].

Carpenter, CL ;

Ross, RK ;

Paganini-Hill, A ;

Bernstein, L .

INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (01) :96-102

[8] IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer [J].

Dool, Carly Jade ;

Mashhedi, Haider ;

Zakikhani, Mahvash ;

David, Stephanie ;

Zhao, Yunhua ;

Birman, Elena ;

Carboni, Joan M. ;

Gottardis, Marco ;

Blouin, Marie-Jose ;

Pollak, Michael .

[9] Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells [J].

Dowling, Ryan J. O. ;

Zakikhani, Mahvash ;

Fantus, I. George ;

Pollak, Michael ;

Sonenberg, Nahum .

CANCER RESEARCH, 2007, 67 (22) :10804-10812

[10] Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I [J].

El-Mir, MY ;

Nogueira, V ;

Fontaine, E ;

Avéret, N ;

Rigoulet, M ;

Leverve, X .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :223-228

← 1 2 3 →